NEW YORK (GenomeWeb News) – Cell Biosciences said today that it has acquired sample-prep company Protein Forest in an all-stock transaction worth an undisclosed amount.

In addition, Cell Biosciences said that in connection with the acquisition, it has raised an additional $4 million in equity financing, led by Novo A/S.

The acquisition adds Protein Forest's digital ProteomeChip product, including instrumentation, software, reagents, and consumables, to Santa Clara, Calif.-based Cell Biosciences' portfolio of protein-analysis products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.